AGE News and Press, AgeX Therapeutics Inc.

Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...

2024-03-25 00:59:35 ET More on AgeX Therapeutics Financial information for AgeX Therapeutics Read the full article on Seeking Alpha For further details see: AgeX Therapeutics GAAP EPS of -$13.73

ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...

(TheNewswire) March 15, 2024 – TheNewswire - Vancouver, BC – Acme Gold Company Limited ( CSE: AGE ) (“Acme” or the “Company”). Management Changes Mark Lotz has resigned as a director and Chief Financial Officer an...

2024-01-25 07:23:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today. Moving stocks this morning are public offerings, earnings reports ...

(NewsDirect) Alligator Energy Ltd (ASX:AGE, OTC:ALGEF) Managing Director and CEO Greg Hall speaks to Thomas Warner from Proactive after the uranium and energy metals project development and exploration group announced two key updates from its Samphire Uranium Project in South Australia. ...

(NewsDirect) Alligator Energy Ltd (ASX:AGE, OTC:ALGEF) CEO Greg Hall discusses with Proactive exploration plans for the company’s Big Lake Uranium Project in South Australia’s Cooper Basin. The ASX-listed company is working on obtaining cultural heritage clearance after agreeing...

Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (Serina), a privately held, clinical stage biotechnology company focused on developing its proprietary ...

2023-11-14 17:15:54 ET More on AgeX Therapeutics Serina Therapeutics and Agex Therapeutics enter merger agreement Financial information for AgeX Therapeutics For further details see: AgeX Therapeutics GAAP EPS of -$0.14, revenue of $0.06M